Tag Archive for: compass pathways

compass pathways psilocybin

Compass Pathways Phase 2 Psilocybin Results far from Spectacular

Psilocybin showed rapid antidepressant effects for most patients, but only 1 in 5 participants showed significant improvement at 12 weeks
Math over Myth

Math Over Myth: Compass and Revive Release Phase 3 Updates but Stocks Drop

,
Math over Myth is your weekly source for psychedelic stock updates, including Compass Pathways and Revive Therapeutics
Math over Myth ATAI Compass

Math Over Myth: Spotlight on Psychedelic Stocks ATAI & COMPASS

,
If you want to invest in psychedelic stocks, ignore the hype and look at the technicals. We take a deep dive on atai Life Sciences & COMPASS Pathways
ARK Invest psychedelic

Psychedelic Stocks: ARK Invest and the Reverse Midas Touch

, ,
Cathie Wood is buying up stocks from the most dubious actors in the psychedelic sector. Given ARK Invest’s subpar performance, is that a good thing?
Compass Pathways Sued

Compass Pathways Sued for Stealing Trade Secrets

,
Compass Pathways faces a legal challenge from Terran Biosciences over the potential theft of intellectual property
Psychedelic Clinical Trials

Three Phase 3 Clinical Trials that Could Legalize Psychedelics

,
The road to psychedelic legalization has many paths. These 3 clinical trials have the best chances to legalize psychedelics for therapy
Psychedelic Stocks Compass Small Pharma Mydecine Awakn

A Big Week for Psychedelic Stocks: 2 CEOs Step Down, MDMA Patents and a Phase 3 Trial

,
Compass Pathways and Small Pharma announce executive shakeup, Mydecine and Awakn push forward with new research
Compass Pathways Appoints a New CEO

Compass Pathways Appoints a New CEO

,
George Goldsmith will be replaced as Compass Pathways CEO. Is this good or bad news?
Compass Pathways Psilocybin Patent Upheld

Compass Pathways Psilocybin Patent Upheld

,
Compass Pathways scores a major victory in their bid to patent Comp 360, a proprietary formulation of psilocybin.
MindMed, atai Life Sciences, Compass Pathways: A Psychedelic Stock AnalysisShutterstock

Comparing MindMed, Atai Life Sciences, Compass Pathways: A Psychedelic Stock Analysis

, ,
Our resident psychedelic investor explains a handful of important metrics to study when analyzing and comparing psychedelic stocks.